Psychiatric comorbidity and medication use in autism: A community survey

Psychiatric Bulletin

Volumn 27, Issue 10, 2003, Pages 378-381

  Morgan, Carlyn N ^a   Roy, Meera ^b   Chance, Patrick ^c  

^a Brooklands Hospital   (United Kingdom)

^b Child and Family Centre   (United Kingdom)

^c Ladywood Home Treatment Team   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CITALOPRAM; DROPERIDOL; FLUOXETINE; HALOPERIDOL; LITHIUM SALT; MIRTAZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PERICIAZINE; PIMOZIDE; PROMAZINE; QUETIAPINE; RISPERIDONE; SULPIRIDE; THIORIDAZINE; TRIFLUOPERAZINE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; AUTISM; BIPOLAR DEPRESSION; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DOWN SYNDROME; DRUG USE; EPILEPSY; FEMALE; FOLLOW UP; GILLES DE LA TOURETTE SYNDROME; HEALTH CARE PLANNING; HUMAN; HYPERTENSION; HYPOTHYROIDISM; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH; PATIENT MONITORING; PICA; PREVALENCE; PSYCHIATRIC DIAGNOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCREENING;

EID: 0142094478     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.27.10.378     Document Type: Article

References (17)

1. Bolton, P.F., Pickles, A. & Murphy, M. (1998) Autism, affective and other psychiatric disorders: Patterns of familiar aggregation. Psychological Medicine, 28, 385-395.
2. Clarke, D. J., Kelly, S. & Thinn, K. (1990) Psychotropic drugs and mental retardation. 1. Disabilities and the prescription of drugs for behaviour and epilepsy in three residential settings. Journal of Mental Deficiency Research, 34, 385-395.
3. Cooper, S. A. (1997) Epidemiology of psychiatric disorders in elderly compared with younger adults with learning disabilities. British Journal of Psychiatry, 170, 375-380.
4. Corbett, J. A. (1979) Psychiatric morbidity and mental retardation. In Psychiatric Illness and Mental Handicap (eds F. E. James & R. P. Snaith), pp. 11-26. Ashford, Kent: Headley Brothers.
5. DeLong, R. & Nohria, C. (1994) Psychiatric family history and neurological disease in autistic spectrum disorders. Developmental Medicine and Child Neurology, 36, 441-448.
6. Fombonne, E. (1999) The epidemiology of autism: A review. Psychological Medicine, 29, 769-786.
7. Kanner, L. (1943) Autistic disturbances of affective contact. Nervous Child, 2, 217-250.
8. Kraijer, D.W. (1997) Autism and Autistic-Like Conditions in Mental Retardation. Lisse: Swets & Zeitlinger.
9. Lainhart, J. E. & Folstein, S. E. (1994) Affective disorders in people with autism: A review of published cases. Journal of Autism and Developmental Disorders, 24, 587-601.
10. Lund, J. (1985) The prevalence of psychiatric morbidity in mentally retarded adults. Acta Psychiatrica Scandinavica, 72, 563-570.
11. McDougle, C. J., Holmes, J. P., Carlson, J. C., et al. (1998) A double blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Archives of General Psychiatry, 55, 633-641.
12. Morgan, C. N., Roy, M., Nasr, A., et al. (2002) A community study establishing the prevalence rate of autistic disorder in adults with learning disability. Psychiatric Bulletin, 26, 127-129.
13. Posey, D. J. & McDougle, C. J. (2000) The pharmacology of target symptoms associated with autistic disorder and other pervasive developmental disorders. Harvard Review of Psychiatry, July/Aug, 45-63.
14. Royal College of Psychiatrists (2001) DC-LD: Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental Retardation. London: Gaskell.
15. Tunbridge, W. M., Evered, D. C. & Hall, R. (1977) The spectrum of thyroid disease in a community: The Whickham survey. Clinical Endocrinology, 7, 481-493.
16. Wing, L. & Gould, J. (1979) Severe impairments of social interaction and associated abnormalities in children: Epidemiology and classification. Journal of Autism and Childhood Schizophrenia, 9, 11-29.
17. World Health Organization (1992) Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD-10). Geneva: WHO.